UnitedHealth Group Inc (NYSE:UNH) Shares Sold by Twin Capital Management Inc.

Twin Capital Management Inc. trimmed its holdings in shares of UnitedHealth Group Inc (NYSE:UNH) by 39.9% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 66,809 shares of the healthcare conglomerate’s stock after selling 44,324 shares during the quarter. UnitedHealth Group makes up approximately 1.1% of Twin Capital Management Inc.’s investment portfolio, making the stock its 18th largest position. Twin Capital Management Inc.’s holdings in UnitedHealth Group were worth $16,302,000 as of its most recent SEC filing.

Several other hedge funds have also made changes to their positions in UNH. Captrust Financial Advisors lifted its position in shares of UnitedHealth Group by 2.7% during the fourth quarter. Captrust Financial Advisors now owns 15,791 shares of the healthcare conglomerate’s stock valued at $3,934,000 after purchasing an additional 419 shares in the last quarter. Geode Capital Management LLC lifted its position in shares of UnitedHealth Group by 9.1% during the fourth quarter. Geode Capital Management LLC now owns 11,593,401 shares of the healthcare conglomerate’s stock valued at $2,882,988,000 after purchasing an additional 965,763 shares in the last quarter. American International Group Inc. lifted its position in shares of UnitedHealth Group by 2.8% during the fourth quarter. American International Group Inc. now owns 325,730 shares of the healthcare conglomerate’s stock valued at $81,146,000 after purchasing an additional 8,796 shares in the last quarter. Thoroughbred Financial Services LLC bought a new position in shares of UnitedHealth Group during the fourth quarter valued at about $1,591,000. Finally, RMB Capital Management LLC lifted its position in shares of UnitedHealth Group by 1.7% during the fourth quarter. RMB Capital Management LLC now owns 53,653 shares of the healthcare conglomerate’s stock valued at $13,366,000 after purchasing an additional 898 shares in the last quarter. 85.65% of the stock is owned by institutional investors and hedge funds.

A number of research analysts recently weighed in on UNH shares. Barclays dropped their price target on shares of UnitedHealth Group from $290.00 to $270.00 and set an “overweight” rating on the stock in a research report on Wednesday, April 17th. Cantor Fitzgerald set a $310.00 price target on shares of UnitedHealth Group and gave the company a “buy” rating in a research report on Friday, July 19th. Cleveland Research reissued a “buy” rating on shares of UnitedHealth Group in a research report on Monday, July 15th. Raymond James raised their price target on shares of UnitedHealth Group from $265.00 to $300.00 and gave the company a “buy” rating in a research report on Friday, July 19th. Finally, Bank of America reissued a “buy” rating and set a $290.00 price target (down from $320.00) on shares of UnitedHealth Group in a research report on Wednesday, April 17th. One investment analyst has rated the stock with a sell rating, one has given a hold rating and eighteen have given a buy rating to the company. UnitedHealth Group has an average rating of “Buy” and a consensus price target of $295.06.

UNH stock traded up $1.16 during mid-day trading on Thursday, hitting $244.36. The company had a trading volume of 123,610 shares, compared to its average volume of 3,513,135. The stock has a market cap of $230.48 billion, a price-to-earnings ratio of 18.98, a PEG ratio of 1.30 and a beta of 0.61. The company has a debt-to-equity ratio of 0.62, a quick ratio of 0.67 and a current ratio of 0.67. UnitedHealth Group Inc has a 12 month low of $208.07 and a 12 month high of $287.94. The firm’s fifty day moving average is $251.31.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Thursday, July 18th. The healthcare conglomerate reported $3.60 EPS for the quarter, topping the consensus estimate of $3.46 by $0.14. The business had revenue of $60.60 billion for the quarter, compared to analyst estimates of $60.59 billion. UnitedHealth Group had a net margin of 5.51% and a return on equity of 25.20%. The company’s revenue for the quarter was up 8.0% on a year-over-year basis. During the same quarter in the previous year, the firm posted $3.14 earnings per share. As a group, sell-side analysts forecast that UnitedHealth Group Inc will post 14.82 EPS for the current year.

In other news, Director Richard T. Burke sold 5,000 shares of UnitedHealth Group stock in a transaction dated Thursday, August 8th. The shares were sold at an average price of $246.40, for a total value of $1,232,000.00. Following the completion of the transaction, the director now owns 187,979 shares in the company, valued at $46,318,025.60. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Richard T. Burke sold 10,000 shares of UnitedHealth Group stock in a transaction dated Wednesday, May 29th. The stock was sold at an average price of $241.99, for a total transaction of $2,419,900.00. Following the completion of the transaction, the director now owns 187,663 shares of the company’s stock, valued at approximately $45,412,569.37. The disclosure for this sale can be found here. In the last ninety days, insiders sold 37,000 shares of company stock worth $9,195,620. Insiders own 0.87% of the company’s stock.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

Featured Story: Dollar Cost Averaging

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.